Silence Therapeutics was required to file disclosures with the Securities and Exchange Commission on July 31, 2026.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Silence Therapeutics was required to file disclosures with the Securities and Exchange Commission on July 31, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Silence Therapeutics
UK business
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Medpace filed required documents with the Securities and Exchange Commission on August 15, 2026.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.
- Disclosure made to the Securities and Exchange Commission involving Northern Trust on July 2, 2026.
- Quince Therapeutics plans to file its financial results with the Securities and Exchange Commission.